• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » INC Research appoints Judith Ng-Cashin chief scientific officer

INC Research appoints Judith Ng-Cashin chief scientific officer

March 14, 2016
CenterWatch Staff

INC Research, a, global phase I to IV CRO, has appointed Judith Ng-Cashin, M.D., as chief scientific officer. Dr. Ng-Cashin will lead the integration of the Company’s industry-recognized therapeutic and medical/scientific expertise for phase I to IV clinical trials. She will be responsible for scientific, medical and ethical governance matters, including collaboration with key medical and scientific stakeholders to strengthen INC’s position as a collaborative partner to clinical practice, sponsor and academic organizations.

“INC has long been recognized as the therapeutically-focused CRO,” said Michael Gibertini, Ph.D., president, Clinical Development. “The appointment of Dr. Judith Ng-Cashin further demonstrates our commitment to providing our customers with high-quality clinical development services grounded in practical medical science and industry-leading therapeutic expertise. With more than 20 years of experience in drug discovery and development, clinical research, bench science and clinical medicine, Dr. Ng-Cashin has distinguished herself in the development of novel therapies. Her proven track record will be invaluable as we work to further connect our medical and therapeutic teams at INC in support of our customers’ clinical development goals.”  

Dr. Ng-Cashin joins INC Research from another top-tier CRO where she served as vice president, Medical Strategy, Office of the CMSO with responsibility for oversight of medical ethics and governance across the global business and most recently as vice president, Advisory Services.  Her experience also includes nine years with GlaxoSmithKline in senior medical leadership roles. Dr. Ng-Cashin’s expertise is wide-ranging, spanning all stages of clinical research and including targeted research in melanoma, HIV and other infectious diseases.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing